EP1539188A4
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
218 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82 Sheet 83 Sheet 84 Sheet 85 Sheet 86 Sheet 87 Sheet 88 Sheet 89 Sheet 90 Sheet 91 Sheet 92 Sheet 93 Sheet 94 Sheet 95 Sheet 96 Sheet 97 Sheet 98 Sheet 99 Sheet 100 Sheet 101 Sheet 102 Sheet 103 Sheet 104 Sheet 105 Sheet 106 Sheet 107 Sheet 108 Sheet 109 Sheet 110 Sheet 111 Sheet 112 Sheet 113 Sheet 114 Sheet 115 Sheet 116 Sheet 117 Sheet 118 Sheet 119 Sheet 120 Sheet 121 Sheet 122 Sheet 123 Sheet 124 Sheet 125 Sheet 126 Sheet 127 Sheet 128 Sheet 129 Sheet 130 Sheet 131 Sheet 132 Sheet 133 Sheet 134 Sheet 135 Sheet 136 Sheet 137 Sheet 138 Sheet 139 Sheet 140 Sheet 141 Sheet 142 Sheet 143 Sheet 144 Sheet 145 Sheet 146 Sheet 147 Sheet 148 Sheet 149 Sheet 150 Sheet 151 Sheet 152 Sheet 153 Sheet 154 Sheet 155 Sheet 156 Sheet 157 Sheet 158 Sheet 159 Sheet 160 Sheet 161 Sheet 162 Sheet 163 Sheet 164 Sheet 165 Sheet 166 Sheet 167 Sheet 168 Sheet 169 Sheet 170 Sheet 171 Sheet 172 Sheet 173 Sheet 174 Sheet 175 Sheet 176 Sheet 177 Sheet 178 Sheet 179 Sheet 180 Sheet 181 Sheet 182 Sheet 183 Sheet 184 Sheet 185 Sheet 186 Sheet 187 Sheet 188 Sheet 189 Sheet 190 Sheet 191 Sheet 192 Sheet 193 Sheet 194 Sheet 195 Sheet 196 Sheet 197 Sheet 198 Sheet 199 Sheet 200 Sheet 201 Sheet 202 Sheet 203 Sheet 204 Sheet 205 Sheet 206 Sheet 207 Sheet 208 Sheet 209 Sheet 210 Sheet 211 Sheet 212 Sheet 213 Sheet 214 Sheet 215 Sheet 216 Sheet 217 Sheet 218
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO02069903A2 | Cites | World Intellectual Property Organization (WIPO) | E | Search report | 1 |
| WO02069903A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| SMEE, DONALD F. ET AL: "Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 31(10), 1535-41 CODEN: AMACCQ; ISSN: 0066-4804, 1987, XP002540074 | Non-patent | – | – | Search report | – |
| DEE NORD L ET AL: "Inhibition of orotidylate decarboxylase by 4(5H)-oxo-1-beta-d-ribofur anosylpyrazolo[3,4-d] pyrimidine-3-thiocarboxamide (APR-TC) in B lymphoblasts - Activation by adenosine kinase", BIOCHEMICAL PHARMACOLOGY, PERGAMON, OXFORD, GB, vol. 37, no. 24, 15 December 1988 (1988-12-15), pages 4697 - 4705, XP023731885, ISSN: 0006-2952, [retrieved on 19881215] | Non-patent | – | – | Search report | – |
| See also references of WO 02057425A2 | Non-patent | – | – | Search report | – |
98 members in 43 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 263313P | United States of America | – | |
| 26331301 | United States of America | P | |
| 282069P | United States of America | – | |
| 28206901 | United States of America | P | |
| 299320P | United States of America | – | |
| 29932001 | United States of America | P | |
| 344528P | United States of America | – | |
| 34452801 | United States of America | P | |
| 0201531 | United States of America | W |
Members98
| Document | Office | Kind | |
|---|---|---|---|
| CA2433878A1 | Canada | A1 | |
| DZ3487A1 | Algeria | A1 | |
| WO02057287A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02057425A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CA2434386A1 | Canada | A1 | |
| PE20020823A1 | Peru | A1 | |
| US2002147160A1 | United States of America | A1 | |
| WO02057287A3 | World Intellectual Property Organization (WIPO) | A3 | |
| IS6860A | Iceland | A | |
| NO20033289D0 | Norway | D0 | |
| ECSP034699A | Ecuador | A | |
| NO20033289L | Norway | L | |
| EE200300338A | Estonia | A | |
| EP1355916A2 | European Patent Office (EPO) | A2 | |
| SK9322003A3 | Slovakia | A3 | |
| IL156641A0 | Israel | A0 | |
| KR20040002854A | Republic of Korea | A | |
| BR0206614A | Brazil | A | |
| BR0206614A | Brazil | A | |
| US2004067901A1 | United States of America | A1 | |
| CZ20032005A3 | Czechia | A3 | |
| US2004072788A1 | United States of America | A1 | |
| EA200300819A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN1498221A | China | A | |
| US2004110717A1 | United States of America | A1 | |
| HU0400726A2 | Hungary | A2 | |
| HUP0400726A2 | Hungary | A2 | |
| AR035736A1 | Argentina | A1 | |
| JP2004520367A | Japan | A | |
| ZA200305078B | South Africa | B | |
| US6777395B2 | United States of America | B2 | |
| BG108000A | Bulgaria | A | |
| JP2004532184A | Japan | A | |
| PL363216A1 | Poland | A1 | |
| MXPA03006514A | Mexico | A | |
| MXPA03006514A | Mexico | A | |
| NZ526703A | New Zealand | A | |
| HK1066014A | Hong Kong, China | A | |
| HK1066014A1 | Hong Kong, China | A1 | |
| WO02057425A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1539188A2 | European Patent Office (EPO) | A2 | |
| HRP20030565A2 | Croatia | A2 | |
| GEP20053601B | Georgia | B | |
| JO2318B1 | Jordan | B1 | |
| UA73843C2 | Ukraine | C2 | |
| US2005272676A1 | United States of America | A1 | |
| YU56903A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| AU2002243791B2 | Australia | B2 | |
| CN1267446C | China | C | |
| TWI261056B | Taiwan Province of China | B | |
| US7105499B2 | United States of America | B2 | |
| US2006205686A1 | United States of America | A1 | |
| AU2002243600B2 | Australia | B2 | |
| EP1707571A1 | European Patent Office (EPO) | A1 | |
| US7125855B2 | United States of America | B2 | |
| EA007491B1 | Eurasian Patent Organization (EAPO) | B1 | |
| US2006264390A1 | United States of America | A1 | |
| CA2434386C | Canada | C | |
| EP1355916B1 | European Patent Office (EPO) | B1 | |
| DE60217465D1 | Germany | D1 | |
| US7202224B2 | United States of America | B2 | |
| PT1355916E | Portugal | E | |
| SI1355916T1 | Slovenia | T1 | |
| DK1355916T3 | Denmark | T3 | |
| JP3914156B2 | Japan | B2 | |
| HU0400726A3 | Hungary | A3 | |
| HUP0400726A3 | Hungary | A3 | |
| ES2278009T3 | Spain | T3 | |
| JP2007224045A | Japan | A | |
| DE60217465T2 | Germany | T2 | |
| US2007275912A1 | United States of America | A1 | |
| MY134070A | Malaysia | A | |
| KR100828453B1 | Republic of Korea | B1 | |
| IS2449B | Iceland | B | |
| CA2433878C | Canada | C | |
| NO326431B1 | Norway | B1 | |
| SK286630B6 | Slovakia | B6 | |
| RS50236B | Serbia | B | |
| EG24465A | Egypt | A | |
| EP1539188A4This record | European Patent Office (EPO) | A4 | |
| PL207405B1 | Poland | B1 | |
| EP2360166A1 | European Patent Office (EPO) | A1 | |
| EP1707571B1 | European Patent Office (EPO) | B1 | |
| AT526339T | Austria | T | |
| ATE526339T1 | Austria | T1 | |
| EP2399588A1 | European Patent Office (EPO) | A1 | |
| HRP20030565B1 | Croatia | B1 | |
| BG66207B1 | Bulgaria | B1 | |
| JP4931683B2 | Japan | B2 | |
| US2012165515A1 | United States of America | A1 | |
| US8481712B2 | United States of America | B2 | |
| EE05709B1 | Estonia | B1 | |
| CY1109012T1 | Cyprus | T1 | |
| US2014309412A1 | United States of America | A1 | |
| EP1539188B1 | European Patent Office (EPO) | B1 | |
| ES2532836T3 | Spain | T3 | |
| US2017183373A1 | United States of America | A1 | |
| EP2399588B1 | European Patent Office (EPO) | B1 |
130 legal events, as 10 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Expiry of rightR071 | R071 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Invalidation of extension of european patentsMG9D | MG9D | LT | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Definitive protectionFG2A | FG2A | ES | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP |
Showing 100 of 130
Numbers
- Publication
- 1539188
- Application
- 27090950
Titles3
- German
- NUKLEOSIDDERIVATE ALS INHIBITOREN DER RNA-ABHÄNGIGEN VIRALEN RNA-POLYMERASE
- English
- NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE
- French
- DERIVES DE NUCLEOSIDE COMME INHIBITEURS DE L'ARN POLYMERASE VIRALE ARN-DEPENDANTE
Classification
- CPC, 20
- C07H19/14
- C07H19/16
- A61K31/7056
- A61K31/7076
- C07D473/00
- C07D487/04
- C07H19/00
- C07H19/06
- C07H19/10
- C07H19/12
- C07H19/20
- A61K38/21
- A61K45/06
- A61K31/7064
- A61K9/4858
- Y02P20/582
- A61P1/16
- A61P31/00
- A61P31/14
- A61P43/00
- IPC, 34
- A61K31 519
- A61K31 70
- A61K31 7052
- A61K31 706
- C07D487 04
- A61K31 7064
- A61K31 7068
- A61K31 7076
- A61K31 708
- A61K31 7105
- A61K31 712
- A61K38 21
- A61K45 00
- A61K45 06
- A61P1 16
- A61P31 14
- A61P43 00
- C07D473 00
- C07D487 02
- C07H
- C07H19 00
- C07H19 04
- C07H19 048
- C07H19 06
- C07H19 067
- C07H19 09
- C07H19 10
- C07H19 14
- C07H19 16
- C07H19 167
- C07H19 173
- C07H19 19
- C07H19 20
- C12N
Designated states26
- Contracting states, 20
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye
- Extension states, 6
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania
- Slovenia
